Skip to content

Clinical trials

Phase 1 Leukemia, Monocytic, Acute trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Monocytic, Acute Phase: Phase 1 Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20046
200510
20062
20071
20081
20091
20102
20111
20122
20133
20142
20152
20201
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated11
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)16
Roswell Park Cancer Institute4
Case Comprehensive Cancer Center3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Masonic Cancer Center, University of Minnesota2
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2
Bruno C. Medeiros1
Children's Oncology Group1
M.D. Anderson Cancer Center1
Memorial Sloan Kettering Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Monocytic, Acute48
Leukemia, Myeloid, Acute45
Leukemia, Erythroblastic, Acute42
Leukemia, Megakaryoblastic, Acute41
Leukemia, Myelomonocytic, Acute41
Congenital Abnormalities32
Precursor Cell Lymphoblastic Leukemia-Lymphoma21
Blast Crisis19
Leukemia18
Leukemia, Basophilic, Acute18

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.